E-CADHERIN EXPRESSION IN GASTROESOPHAGEAL REFLUX DISEASE, BARRETTS-ESOPHAGUS, AND ESOPHAGEAL ADENOCARCINOMA - AN IMMUNOHISTOCHEMICAL AND IMMUNOBLOT STUDY
S. Swami et al., E-CADHERIN EXPRESSION IN GASTROESOPHAGEAL REFLUX DISEASE, BARRETTS-ESOPHAGUS, AND ESOPHAGEAL ADENOCARCINOMA - AN IMMUNOHISTOCHEMICAL AND IMMUNOBLOT STUDY, The American journal of gastroenterology, 90(10), 1995, pp. 1808-1813
Background/Aims: Cadherins are cell adhesion molecules that are though
t to play a vital role in cell-cell adhesion; loss or down-regulation
of their expression has been implicated in neoplasia. Barrett's esopha
geal columnar metaplasia (BE) is a premalignant lesion for esophageal
adenocarcinoma with clinical symptoms similar to those of gastroesopha
geal reflux disease and esophagitis. In this study, we investigated th
e potential relationship between E-cadherin expression and inflammatio
n, metaplasia, and carcinogenesis in esophagitis, BE, and esophageal a
denocarcinoma. Methods: Endoscopically obtained mucosal biopsy specime
ns of esophagitis (n = 6), BE with or without dysplasia (n = 16), and
esophageal adenocarcinoma (n = 6) were analyzed for the expression of
E-cadherin by both Western analysis and immunoperoxidase staining. Res
ults: Densitometric analysis of Western blots revealed the expression
of E-cadherin to be significantly lower in patients with BE compared w
ith normal esophageal epithelium, regardless of the presence or absenc
e of dysplasia (p < 0.03). No significant differences were noticed bet
ween the normal esophagus and the esophagitis groups. In the adenocarc
inoma group, one patient showed complete loss of E-cadherin expression
, and the other five patients showed significantly reduced expression
that was even lower than that in BE (p < 0.01). Immunoperoxidase stain
ing matched the Western analysis results. Conclusions: We conclude tha
t loss of or reduced E-cadherin expression may play a role in the prog
ression of BE to adenocarcinoma.